1. Home
  2. CRDL vs BSET Comparison

CRDL vs BSET Comparison

Compare CRDL & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.49

Market Cap

154.1M

Sector

Health Care

ML Signal

HOLD

Logo Bassett Furniture Industries Incorporated

BSET

Bassett Furniture Industries Incorporated

HOLD

Current Price

$14.70

Market Cap

153.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDL
BSET
Founded
2017
1902
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
154.1M
153.2M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
CRDL
BSET
Price
$1.49
$14.70
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
1.0M
29.1K
Earning Date
05-13-2026
04-01-2026
Dividend Yield
N/A
5.52%
EPS Growth
N/A
163.06
EPS
N/A
0.13
Revenue
N/A
$456,855,000.00
Revenue This Year
N/A
$4.26
Revenue Next Year
N/A
$4.46
P/E Ratio
N/A
$111.46
Revenue Growth
N/A
0.96
52 Week Low
$0.88
$13.17
52 Week High
$1.59
$19.75

Technical Indicators

Market Signals
Indicator
CRDL
BSET
Relative Strength Index (RSI) 69.76 52.98
Support Level $0.95 $13.43
Resistance Level $1.59 $14.69
Average True Range (ATR) 0.10 0.59
MACD 0.01 0.09
Stochastic Oscillator 95.74 80.23

Price Performance

Historical Comparison
CRDL
BSET

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About BSET Bassett Furniture Industries Incorporated

Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.

Share on Social Networks: